Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2008 1
2009 1
2010 1
2011 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Huntington's disease and minocycline.
Hödl AK, Bonelli RM. Hödl AK, et al. Mov Disord. 2005 Apr;20(4):510-1; author reply 511. doi: 10.1002/mds.20441. Mov Disord. 2005. PMID: 15806589 No abstract available.
Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY.
Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB; Investigators of the European Huntington's Disease Network. Orth M, et al. Version 2. PLoS Curr. 2010 Sep 28;2:RRN1184. doi: 10.1371/currents.RRN1184. PLoS Curr. 2010. PMID: 20890398 Free PMC article.
BACKGROUND: Huntington's disease (HD) is a rare triplet repeat (CAG) disorder. Advanced, multi-centre, multi-national research frameworks are needed to study simultaneously multiple complementary aspects of HD. ...METHODS: We report on cross-sectional data of the first 176 …
BACKGROUND: Huntington's disease (HD) is a rare triplet repeat (CAG) disorder. Advanced, multi-centre, multi-national research framew …
NMDA receptor gene variations as modifiers in Huntington disease: a replication study.
Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, de Yebenes JG, Dose M, Tabrizi SJ, Craufurd D; REGISTRY Investigators of the European Huntington's Disease Network, Arning L. Saft C, et al. PLoS Curr. 2011 Oct 4;3:RRN1247. doi: 10.1371/currents.RRN1247. PLoS Curr. 2011. PMID: 21989477 Free PMC article.
Several candidate modifier genes which, in addition to the pathogenic CAG repeat expansion, influence the age at onset (AO) in Huntington disease (HD) have already been described. The aim of this study was to replicate association of variations in the N-methyl D-aspartate …
Several candidate modifier genes which, in addition to the pathogenic CAG repeat expansion, influence the age at onset (AO) in Huntington …
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease.
Aziz NA, Jurgens CK, Landwehrmeyer GB; EHDN Registry Study Group, van Roon-Mom WM, van Ommen GJ, Stijnen T, Roos RA. Aziz NA, et al. Neurology. 2009 Oct 20;73(16):1280-5. doi: 10.1212/WNL.0b013e3181bd1121. Epub 2009 Sep 23. Neurology. 2009. PMID: 19776381 Clinical Trial.
OBJECTIVE: Huntington disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG repeat expansion in the HD gene (HTT). ...CONCLUSIONS: Increasing CAG repeat size in normal HTT diminishes the association between mutant CAG repeat size and disease seve …
OBJECTIVE: Huntington disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG repeat expansion in the HD gen …
Ideomotor limb apraxia in Huntington's disease: a case-control study.
Hödl AK, Hödl E, Otti DV, Herranhof B, Ille R, Bonelli RM. Hödl AK, et al. J Neurol. 2008 Mar;255(3):331-9. doi: 10.1007/s00415-008-0577-4. Epub 2008 Mar 4. J Neurol. 2008. PMID: 18305889
However, this symptom may also occur in dementia with subcortical lesions like Huntington's disease (HD), a hereditary, devastating neurodegenerative disease leading to neurological and psychiatric dysfunction. ...
However, this symptom may also occur in dementia with subcortical lesions like Huntington's disease (HD), a hereditary, devastating n …
Impaired ideomotor limb apraxia in cortical and subcortical dementia: a comparison of Alzheimer's and Huntington's disease.
Holl AK, Ille R, Wilkinson L, Otti DV, Hödl E, Herranhof B, Reisinger KM, Müller N, Painold A, Holl EM, Letmaier M, Bonelli RM. Holl AK, et al. Neurodegener Dis. 2011;8(4):208-15. doi: 10.1159/000322230. Epub 2011 Jan 5. Neurodegener Dis. 2011. PMID: 21212634
BACKGROUND: Although ideomotor limb apraxia is often considered to occur only in dementia with cortical involvement like Alzheimer's disease (AD), it is also frequently seen in dementia with subcortical degeneration like Huntington's disease (HD). ...
BACKGROUND: Although ideomotor limb apraxia is often considered to occur only in dementia with cortical involvement like Alzheimer's disease …
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Bonelli RM, Hödl AK, Hofmann P, Kapfhammer HP. Bonelli RM, et al. Int Clin Psychopharmacol. 2004 Nov;19(6):337-42. doi: 10.1097/00004850-200411000-00004. Int Clin Psychopharmacol. 2004. PMID: 15486519 Clinical Trial.
Huntington's disease (HD), a relentlessly progressive neurodegenerative disorder, is characterized by a clinical triad of psychiatric, cognitive and motor disturbances. ...
Huntington's disease (HD), a relentlessly progressive neurodegenerative disorder, is characterized by a clinical triad of psychiatric …
Feedback